An oxazole-linked donor–acceptor covalent organic framework as an efficient electrocatalyst for lithium–sulfur batteries
Journal of Materials Chemistry A · 2025 · 13 (5) · 3392-3401
DOI: 10.1039/d4ta07994a ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Materials Chemistry A, 2025. Verfasst von Xuanhe Hu und 6 weiteren Autor:innen. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Basic and Applied Basic Research Foundation of Guangdong Province, Guangzhou Municipal Science and Technology Program key projects.
Abstract (Originalsprache)
An oxazole-linked donor–acceptor COF (BTT-DABD) is developed and demonstrated as an excellent electrocatalyst for lithium–sulfur batteries. The oxazole linkage endows BTT-DABD with enhanced chemical stability and catalytic activity.
Förderung
- National Natural Science Foundation of China
- Basic and Applied Basic Research Foundation of Guangdong Province
- Guangzhou Municipal Science and Technology Program key projects
Zitieren
APA
Hu, X., Zhang, G., Liang, H., Li, J., Zhou, H., Chung, L., & He, J. (2025). An oxazole-linked donor–acceptor covalent organic framework as an efficient electrocatalyst for lithium–sulfur batteries. Journal of Materials Chemistry A, 13(5), 3392-3401. https://doi.org/10.1039/d4ta07994a
Vancouver
Hu X, Zhang G, Liang H, Li J, Zhou H, Chung L, et al. An oxazole-linked donor–acceptor covalent organic framework as an efficient electrocatalyst for lithium–sulfur batteries. Journal of Materials Chemistry A. 2025;13(5):3392-3401. doi:10.1039/d4ta07994a
BibTeX
@article{Hu2025,
author = {Hu, Xuanhe and Zhang, Gengyuan and Liang, Hongyuan and Li, Jiangtao and Zhou, Hujing and Chung, Lai-Hon and He, Jun},
title = {An oxazole-linked donor–acceptor covalent organic framework as an efficient electrocatalyst for lithium–sulfur batteries},
journal = {Journal of Materials Chemistry A},
year = {2025},
volume = {13},
number = {5},
pages = {3392--3401},
doi = {10.1039/d4ta07994a}
}
EUVIMED